missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant SARS-CoV-2 BA.2 Spike RBD Fc Chimera Protein
Omicron Variant
Brand: R&D Systems™ 11148-CV-100
This item is not returnable.
View return policy
Description
Measured by its binding ability in a functional ELISA with Recombinant Human ACE-2 His-tag (Catalog # 933-ZN ).Specifications
| YP_009724390.1 | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| Unconjugated | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Bioactivity | |
| M.W.-observed: 59-65 kDa, under reducing conditions., M.W.-theroretical: 52 kDa | |
| Human embryonic kidney cell, HEK293-derived sars-cov-2 Spike RBD protein SARS-CoV-2 BA0.2 Spike RBD (Arg319-Phe541) (Gly339Asp, Ser371Phe, Ser373Pro, Ser375Phe, Thr376Ala, Asp405Asn, Arg408Ser, Lys417Asn, Asn440Lys, Ser477Asn, Thr478Lys, Glu484Ala, Gln493Arg, Gln498Arg, Asn501Tyr, Tyr505His) (C-terminus) Accession # YP_009724390.1 IEGRMD Human IgG1 (Pro100-Lys330) (N-terminus) | |
| <0.10 EU / 1 μg of the protein by the LAL method. | |
| Reconstitute at 500 μg/mL in PBS. | |
| Spike RBD |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction